4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-21-000545
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Soni Manmeet Singh · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-19 | Grant or award : show line 1 in the form Stock Option (right to buy) | +25,000 | 252,273 | D |
Loading xslF345X03/form412566sin_02232021.xml…